Navigation Links
Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
Date:3/30/2009

COSTA MESA, Calif., March 30 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) will hold an investor presentation meeting for shareholders, prospective investors and interested parties in Zurich, Switzerland on April 1, 2009. The purpose of the meeting will be to update the investment community on the company's business.

Company chairman and CEO Chris J. Stern will be available to answer shareholder questions along with the co-chairs of the company's medical advisory board, Dr. Bruce D. Spiess, M.D., FAHA - Professor Anesthesiology and Emergency Medicine, VCURES/ VCU Med Center Richmond, Virginia and Dr. Ross Bullock, M.D. Ph.D.- Professor of Neurosurgery, University of Miami, Miami, Florida.

The three will be in Switzerland in connection with the clinical investigator meeting, a formal initiating step for the Swiss Phase II clinical trial of Oxycyte(R) in traumatic brain injury. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

The meeting will be webcast live with the webcast available via the investor relations page of the company website.

    Meeting details are as follows:
          Location:   Radisson SAS Zurich Airport Hotel
          Time:       1:00 p.m. - 3:00 p.m. local time (7:00 a.m. - 9:00
                      a.m. eastern time)
          Language:   The meeting language will be English

"This will give European investors a chance to participate in a discussion with management and key researchers," said Stern. "We are also planning a meeting of this type in the U.S. later this year."

    What:     Live webcast of Zurich Investor Meeting

    When:     April 1, 2009 at 1:00 p.m. Zurich time (7:00 a.m. EDT)

    Where:    The live webcast will be available via the investor relations
              page of the company website at www.Oxybiomed.com or directly
              at:http://www.videonewswire.com/event.asp?id=57069

    How:      Live over the Internet -- Simply log on to the web at the
              address above.

    Contact:  Abe Wischnia of Abe Wischnia & Associates at 619-795-2345

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The company has under development a perfluorocarbon therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis pain, trauma, wound care, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, and diabetes. More information is available at www.oxybiomed.com.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from

http://www.microsoft.com and at least a 56Kbps connection to the Internet.

If you experience problems listening to the webcast, send an E-mail to: webcast@multivu.com.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
4. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
7. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
8. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
9. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
10. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... 13, 2017 Research and Markets has announced ... - Global Forecast to 2021" report to their offering. ... The biosimilars market ... 3.39 Billion in 2016, at a CAGR of 26.3%. ... product, manufacturing type, and application. Factors such as rising incidence of ...
(Date:1/13/2017)... ... January 13, 2017 , ... FireflySci ... it has found among its diverse customer base. The latest entry in this ... brands electroporators including BTX and Bio-Rad. FireflySci is introducing three distinct varieties including ...
(Date:1/12/2017)... ... , ... Each year, Crain’s Detroit Business News ranks the most innovative companies ... estate of a company, its impact and significance, and the likelihood of bringing it ... technologies that transform energy sources such as low dose X-ray and convert them into ...
(Date:1/12/2017)... AURORA, Colo (PRWEB) , ... January 12, 2017 ... ... and then to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a ... eLife describes a new drug combination that has stabilized Rosendahl’s disease and increased ...
Breaking Biology Technology:
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
(Date:12/7/2016)... December 7, 2016 According to a new market research ... Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - ... grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, ... Continue Reading ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):